TEHRAN – The challenge of unfair sanctions against Iran not only increases the cost of implementing treatment and harm reduction programs, but also challenges the challenge of developing effective strategies to combat drug trafficking, said the executive director of Iran’s Drug Management Headquarters (DCHQ).
Brigadier General Hossein Zolfaqari praised the United Nations Office on Drugs and Crime (UNODC)’s efforts, highlighting the dangerous evolution of the global drug problem, the IRNA reported.
Officials made their remarks while dealing with the 68th session of the United Nations Narcotics Commission (CND) on Narcotics (CND) held in Vienna, Austria, from March 10th to 14th.
Despite all the efforts made to overcome the problem, national and international drug management systems are struggling with the rapid emergence of new psychoactive substances (NPS), Zolfaqari emphasized.
Officials proposed several ways to better treat drug and drug-related issues, highlighting the need to expand cooperation, enhance mechanisms for information exchange, share experience, provide technical assistance and equipment, and transfer the necessary technologies to countries affected by illegal production, transport and consumption of drugs.
Diversifying treatment methods and promoting access to drugs for medical purposes is one of the nation’s top priorities to reduce the demand for illegal use of drugs. Therefore, he added, it is essential to promote the exchange of current expertise and findings.
To cooperate in the field of drug enforcement, referring to successful initiatives that have been suspended or partially active, such as agreements supported by the UNODC between Iran, Afghanistan, and Pakistan, Zolfakari is expected to fund UNODC to support such local agreements.
“In line with the implementation of the majority resolutions of the Drug Commission and the Human Rights Council, we are calling for the end of sanctions and the procurement of effective technical and equipment support to the country at the forefront of the fight against drugs,” Zolfakari further pointed out.
In addition to giving speeches in high-level segments, Zolfakari will also hold bilateral and multilateral meetings with Drug Committee officials, executive director of UNODC, president of the International Drug Management Board (INCB).
Additionally, with the support and participation of UNODC, it is planned to share the national experience of harm reduction, prevention, treatment, rehabilitation and reunification of the recovered population with society, and notify participants, experts and experts of measures taken in this regard.
Narcotics Committee
The CND is the central policy-making body within the United Nations system to address all drug-related issues. It examines the global drug situation, promotes international drug management mechanisms, and identifies the satisfaction level of international organizations in the field of drug management.
It reviews the global drug situation, takes a balanced approach to the interrelated issues of illicit drug demand, supply and human trafficking, monitors the implementation of international practices on drugs, psychotropic substances and chemicals, provides recommendations to enhance international drug management activities, provides recommendations to promote scientific research and exchange information, and supports the performance of the CND Economic and Social Council. Policy governing the United Nations Office on UN Drugs and Crime (UNODC) activities and its financial resources.
mt/mg